142 related articles for article (PubMed ID: 7927891)
1. Distribution of oncofetal fibronectin isoforms in normal, hyperplastic and neoplastic human breast tissues.
Kaczmarek J; Castellani P; Nicolo G; Spina B; Allemanni G; Zardi L
Int J Cancer; 1994 Oct; 59(1):11-6. PubMed ID: 7927891
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical fibronectin staining pattern and prognosis in invasive breast carcinoma.
Takei H; Iino Y; Horiguchi J; Yokoe T
Oncology; 1995; 52(2):106-11. PubMed ID: 7854768
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix proteins and their receptors in the normal, hyperplastic and neoplastic breast.
Gould VE; Koukoulis GK; Virtanen I
Cell Differ Dev; 1990 Dec; 32(3):409-16. PubMed ID: 1711920
[TBL] [Abstract][Full Text] [Related]
4. Oncofetal fibronectins in oral carcinomas: correlation of two different types.
Mandel U; Gaggero B; Reibel J; Therkildsen MH; Dabelsteen E; Clausen H
APMIS; 1994 Sep; 102(9):695-702. PubMed ID: 7946273
[TBL] [Abstract][Full Text] [Related]
5. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.
Brown LF; Guidi AJ; Schnitt SJ; Van De Water L; Iruela-Arispe ML; Yeo TK; Tognazzi K; Dvorak HF
Clin Cancer Res; 1999 May; 5(5):1041-56. PubMed ID: 10353737
[TBL] [Abstract][Full Text] [Related]
6. The fibronectin isoform containing the ED-B oncofetal domain: a marker of angiogenesis.
Castellani P; Viale G; Dorcaratto A; Nicolo G; Kaczmarek J; Querze G; Zardi L
Int J Cancer; 1994 Dec; 59(5):612-8. PubMed ID: 7525495
[TBL] [Abstract][Full Text] [Related]
7. The oncofetal domain of fibronectin defined by monoclonal antibody FDC-6: its presence in fibronectins from fetal and tumor tissues and its absence in those from normal adult tissues and plasma.
Matsuura H; Hakomori S
Proc Natl Acad Sci U S A; 1985 Oct; 82(19):6517-21. PubMed ID: 2995969
[TBL] [Abstract][Full Text] [Related]
8. Expression of fibronectin isoforms in human breast tissue: production of extra domain A+/extra domain B+ by cancer cells and extra domain A+ by stromal cells.
Matsumoto E; Yoshida T; Kawarada Y; Sakakura T
Jpn J Cancer Res; 1999 Mar; 90(3):320-5. PubMed ID: 10359047
[TBL] [Abstract][Full Text] [Related]
9. Distribution of oncofetal fibronectin in human mammary tumors: immunofluorescence study on histological sections.
Loridon-Rosa B; Vielh P; Matsuura H; Clausen H; Cuadrado C; Burtin P
Cancer Res; 1990 Mar; 50(5):1608-12. PubMed ID: 2406016
[TBL] [Abstract][Full Text] [Related]
10. Distribution of fibronectin isoforms in human renal disease.
Van Vliet A; Baelde HJ; Vleming LJ; de Heer E; Bruijn JA
J Pathol; 2001 Feb; 193(2):256-62. PubMed ID: 11180174
[TBL] [Abstract][Full Text] [Related]
11. Fibronectin isoforms are differentially expressed in normal and adenomatous human anterior pituitaries.
Farnoud MR; Farhadian F; Samuel JL; Derome P; Peillon F; Li JY
Int J Cancer; 1995 Mar; 61(1):27-34. PubMed ID: 7705930
[TBL] [Abstract][Full Text] [Related]
12. Distribution of tenascin, cellular fibronectins and integrins in the normal, hyperplastic and neoplastic breast.
Koukoulis GK; Howeedy AA; Korhonen M; Virtanen I; Gould VE
J Submicrosc Cytol Pathol; 1993 Apr; 25(2):285-95. PubMed ID: 7686813
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated changes in glycosylation of fibronectin. Immunohistological localization of oncofetal fibronectin defined by monoclonal antibodies.
Mandel U; Hamilton Therkildsen M; Reibel J; Sweeney B; Matsuura H; Hakomori S; Dabelsteen E; Clausen H
APMIS; 1992 Sep; 100(9):817-26. PubMed ID: 1389100
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical localization of integrins in the normal, hyperplastic, and neoplastic breast. Correlations with their functions as receptors and cell adhesion molecules.
Koukoulis GK; Virtanen I; Korhonen M; Laitinen L; Quaranta V; Gould VE
Am J Pathol; 1991 Oct; 139(4):787-99. PubMed ID: 1928301
[TBL] [Abstract][Full Text] [Related]
15. Expression of c-kit in common benign and malignant breast lesions.
Kondi-Pafiti A; Arkadopoulos N; Gennatas C; Michalaki V; Frangou-Plegmenou M; Chatzipantelis P
Tumori; 2010; 96(6):978-84. PubMed ID: 21388062
[TBL] [Abstract][Full Text] [Related]
16. The oncofetal structure of human fibronectin defined by monoclonal antibody FDC-6. Unique structural requirement for the antigenic specificity provided by a glycosylhexapeptide.
Matsuura H; Takio K; Titani K; Greene T; Levery SB; Salyan ME; Hakomori S
J Biol Chem; 1988 Mar; 263(7):3314-22. PubMed ID: 2449438
[TBL] [Abstract][Full Text] [Related]
17. A tumor-associated fibronectin isoform generated by alternative splicing of messenger RNA precursors.
Carnemolla B; Balza E; Siri A; Zardi L; Nicotra MR; Bigotti A; Natali PG
J Cell Biol; 1989 Mar; 108(3):1139-48. PubMed ID: 2646306
[TBL] [Abstract][Full Text] [Related]
18. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast.
Gould VE; Koukoulis GK; Jansson DS; Nagle RB; Franke WW; Moll R
Am J Pathol; 1990 Nov; 137(5):1143-55. PubMed ID: 1700618
[TBL] [Abstract][Full Text] [Related]
19. Combined overexpression of urokinase, urokinase receptor, and plasminogen activator inhibitor-1 is associated with breast cancer progression: an immunohistochemical comparison of normal, benign, and malignant breast tissues.
Costantini V; Sidoni A; Deveglia R; Cazzato OA; Bellezza G; Ferri I; Bucciarelli E; Nenci GG
Cancer; 1996 Mar; 77(6):1079-88. PubMed ID: 8635127
[TBL] [Abstract][Full Text] [Related]
20. Expression of fibronectin splice variants and oncofetal glycosylated fibronectin in the synovial membranes of patients with rheumatoid arthritis and osteoarthritis.
Kriegsmann J; Berndt A; Hansen T; Borsi L; Zardi L; Bräuer R; Petrow PK; Otto M; Kirkpatrick CJ; Gay S; Kosmehl H
Rheumatol Int; 2004 Jan; 24(1):25-33. PubMed ID: 12712258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]